Key result
Anticoagulant therapy in acute presumed ischaemic stroke shows unclear effect on death or dependency.
Systematic Review
Answers are grounded in this paper and cite their sources.
Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 1 Dead or dependent at end of follow up (if > 1 month). . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.2.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 2 Death from all causes during treatment period. . . . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.3.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 3 Death from all causes at final follow up (if > 1 month). . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.4.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 4 Deep vein thrombosis during treatment period. . . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.5.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 5 Symptomatic pulmonary embolism during treatment period. . . . . . . . . . . . . . . . . . . . . . .Analysis 1.6.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 6 Recurrent ischaemic or unknown stroke during treatment period. . . . . . . . . . . . . . . . . . . .Analysis 1.7.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 7 Symptomatic intracranial haemorrhage during treatment period. . . . . . . . . . . . . . . . . . . . . .Analysis 1.8.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 8 Any recurrent stroke or symptomatic intracranial haemorrhage during treatment period or follow up (> 1 month). . . . .Analysis 1.9.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 9 Major extracranial haemorrhage during treatment period. . . . . . . . . . . . . . . . . . . . . . . . . .Analysis 1.10.Comparison 1 Anticoagulant versus control in acute presumed ischaemic stroke, Outcome 10 Subgroup analysis by anticoagulant dose: effect on death or dependency. . . . . . . . . . . . . . . . . .
No takes yet. Share an insight, caveat, or question.
A 2015 study conducted a systematic review in Acute presumed ischaemic stroke. Anticoagulant vs. Control was evaluated on Dead or dependent at end of follow up (if > 1 month). Anticoagulant therapy versus control in acute presumed ischaemic stroke was evaluated for death or dependency at >1 month follow-up, though no numerical results are reported in the abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: